Medtronic PLC
$ 80.20
-0.16%
12 Jun - close price
- Market Cap 102,967,566,000 USD
- Current Price $ 80.20
- High / Low $ 80.74 / 79.26
- Stock P/E 21.50
- Book Value 38.17
- EPS 3.73
- Next Earning Report -
- Dividend Per Share $2.84
- Dividend Yield 3.54 %
- Next Dividend Date 2026-07-17
- ROA 0.05 %
- ROE 0.10 %
- 52 Week High 104.70
- 52 Week Low 73.31
About
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Analyst Target Price
$98.00
Quarterly Earnings
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-06-03 | 2026-02-17 | 2025-11-18 | 2025-08-19 | 2025-05-21 | 2025-02-18 | 2024-11-19 | 2024-08-20 | 2024-05-23 | 2024-02-20 | 2023-11-21 | 2023-08-22 |
| Reported EPS | 1.55 | 1.36 | 1.36 | 1.26 | 1.62 | 1.39 | 1.26 | 1.23 | 1.46 | 1.3 | 1.25 | 1.2 |
| Estimated EPS | 1.56 | 1.34 | 1.31 | 1.23 | 1.58 | 1.36 | 1.25 | 1.2 | 1.45 | 1.26 | 1.18 | 1.11 |
| Surprise | -0.01 | 0.02 | 0.05 | 0.03 | 0.04 | 0.03 | 0.01 | 0.03 | 0.01 | 0.04 | 0.07 | 0.09 |
| Surprise Percentage | -0.641% | 1.4925% | 3.8168% | 2.439% | 2.5316% | 2.2059% | 0.8% | 2.5% | 0.6897% | 3.1746% | 5.9322% | 8.1081% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-17 | 2026-01-16 | 2025-10-17 | 2025-07-11 | 2025-04-11 | 2025-01-10 | 2024-10-11 | 2024-07-12 | 2024-04-12 | 2024-01-12 |
| Amount | $0.71 | $0.71 | $0.71 | $0.71 | $0.7 | $0.7 | $0.7 | $0.7 | $0.69 | $0.69 |
Next Dividend Records
| Dividend per share (year): | $2.84 |
| Dividend Yield | 3.54% |
| Next Dividend Date | 2026-07-17 |
| Ex-Dividend Date | 2026-06-26 |
Recent News: MDT
2026-06-14 19:36:59
Abbott recently announced its 410th consecutive quarterly dividend of US$0.63 per share and launched its CE-marked dual glucose-ketone Libre Duo sensors in Europe, expanding its diabetes technology offerings. This combination of consistent cash returns and innovation strengthens Abbott's investment narrative, particularly its diabetes technology segment. While the Libre Duo launch enhances their market position, investors should also consider potential competitive pressures in glucose monitoring and US competitive bidding risks.
2026-06-14 11:22:05
BofA (Bank of America) reduced its price target on Medtronic (MDT) stock to $95 from $110, while maintaining a "Buy" rating, citing a lower utilization environment and inflation concerns for 2027 med-tech estimates. Goldman Sachs analyst David Roman also maintained a "Hold" rating on MDT, noting a balanced risk-reward profile with strong top-line momentum offset by increased reinvestment. Medtronic is a medical device company, and the article suggests that while MDT has potential, certain AI stocks might offer higher returns in a shorter timeframe.
2026-06-14 11:15:00
BofA has lowered its price target on Medtronic (MDT) stock to $95 from $110, maintaining a "Buy" rating, due to a lower utilization environment and inflation impacting med-tech company estimates for 2027. This more conservative outlook considers the hurdle of inflation for med-tech in 2027, leading to reduced 2027 estimates across larger-cap companies. Goldman Sachs also maintained a "Hold" rating, noting a balanced risk-reward profile with strong top-line momentum but limited earnings benefit due to reinvestment and portfolio mix.
2026-06-14 08:38:00
Epoch Investment Partners Inc. reduced its stake in Medtronic PLC by 5.4% in the fourth quarter, selling 49,576 shares, though still holding 868,910 shares valued at approximately $83.5 million. Medtronic reported strong quarterly results, beating EPS estimates and achieving 9.9% year-over-year revenue growth, while also increasing its quarterly dividend to $0.72 per share. Analyst consensus rates Medtronic as a "Moderate Buy" with a target price of $99.
2026-06-14 08:08:03
Avidity Partners Management LP decreased its stake in Medtronic PLC (MDT) by 43.5% in the fourth quarter, although "MDT" remains its 7th largest holding, representing about 3% of its portfolio. Medtronic reported solid quarterly results with EPS of $1.55 and revenue up 9.9% year-over-year, and has raised its quarterly dividend to $0.72 per share. Analysts currently rate the stock as a "Moderate Buy" with a consensus price target of $99.00.
2026-06-14 07:18:38
Stryker recently launched its TPX HD premium small bone power tool, which integrates into its broader surgical ecosystem. While the launch reinforces Stryker's focus on advanced hardware and integrated workflows, the article notes that its impact on near-term catalysts is limited, with robotics adoption and international expansion remaining key. Investors should also consider ongoing operational pressures like supply chain constraints and cost inflation, which could affect margins despite strong demand and innovation.
